Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals plc | President & COO | Ordinary Shares | 55.4K | $6.38M | $115.21 | Apr 5, 2024 | Direct |
Gossamer Bio, Inc. | Director | Stock Option (Right to Buy) | 35K | Jun 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JAZZ | Jazz Pharmaceuticals plc | Apr 5, 2024 | 1 | -$200K | 4 | Apr 9, 2024 | President & COO |
JAZZ | Jazz Pharmaceuticals plc | Mar 5, 2024 | 1 | -$426K | 4 | Mar 7, 2024 | President & COO |
JAZZ | Jazz Pharmaceuticals plc | Mar 1, 2024 | 1 | $0 | 4 | Mar 5, 2024 | President & COO |
JAZZ | Jazz Pharmaceuticals plc | Jan 17, 2024 | 2 | -$382K | 4 | Jan 19, 2024 | President & COO |
JAZZ | Jazz Pharmaceuticals plc | Nov 10, 2023 | 1 | $0 | 4 | Nov 14, 2023 | President & COO |
GOSS | Gossamer Bio, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
JAZZ | Jazz Pharmaceuticals plc | May 18, 2023 | 1 | -$790K | 4 | May 19, 2023 | EVP & Chief Financial Officer |
JAZZ | Jazz Pharmaceuticals plc | Apr 5, 2023 | 1 | -$263K | 4 | Apr 7, 2023 | EVP & Chief Financial Officer |
JAZZ | Jazz Pharmaceuticals plc | Mar 3, 2023 | 2 | -$222K | 4 | Mar 7, 2023 | EVP & Chief Financial Officer |
JAZZ | Jazz Pharmaceuticals plc | Dec 21, 2022 | 1 | -$422K | 4 | Dec 22, 2022 | EVP & Chief Financial Officer |
GOSS | Gossamer Bio, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jul 15, 2022 | Director |
JAZZ | Jazz Pharmaceuticals plc | Apr 5, 2022 | 1 | -$266K | 4 | Apr 7, 2022 | EVP & CFO |
JAZZ | Jazz Pharmaceuticals plc | Mar 3, 2022 | 2 | -$111K | 4 | Mar 9, 2022 | EVP & CFO |
GOSS | Gossamer Bio, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |